FIELD: organic chemistry, polypeptides, pharmacy. SUBSTANCE: invention relates to polypeptide compound of the general formula (I) where R1 means lower alkanoyl group substituted with unsaturated 6-membered heteromonocyclic group containing at least one nitrogen atom that can has one or some suitable substituents; lower alkanoyl group substituted with 1,2,3,4-tetrahydroisoquinoline that can has one or some suitable substituents; lower alkanoyl group substituted with unsaturated condensed heterocyclic group containing at least one oxygen atom that can has one or some suitable substituents, or to their pharmaceutically acceptable salts. Compounds show antibacterial activity, in part, antifungal activity and activity inhibiting effect of β-1,3-glucane synthase. Except for, invention relates to method of synthesis of indicated compounds and pharmaceutical compositions containing these compounds. Compounds can be used for prophylaxis and/or therapeutic treatment of patients with infectious diseases including infection caused by Pneumocystis carinii, for example, pneumonia caused by Pneumocystis carinii in humans or animals. EFFECT: improved method of synthesis, valuable medicinal properties. 8 cl, 2 tbl
Title |
Year |
Author |
Number |
DERIVATIVES OF N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE AS ANTAGONISTS OF PLATELET ACTIVATION FACTOR, METHOD OF SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT |
1994 |
- Mitsuru Okhkubo
- Fumie Takakhasi
- Tosio Jamanaka
- Khiroesi Sakai
- Masajuki Kato
|
RU2161155C2 |
HETEROCYCLIC COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND INTERMEDIATE COMPOUNDS |
1994 |
- Taniguti Kiesi
- Nagano Masanobu
- Khattori Kojudzi
- Tsubaki Kazunori
- Okitsu Osamu
- Tabuti Sejitiro
|
RU2176640C2 |
HETEROBICYCLIC DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION |
1995 |
- Norikhiko Simazaki
- Sinja Vatanabe
- Akikhiko Savada
- Kejdzi Khemmi
|
RU2170737C2 |
POLYPEPTIDE COMPOUNDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF PROPHYLAXIS AND/OR THERAPEUTIC TREATMENT |
1994 |
- Khidenori Okhki
- Masaki Tomisima
- Akira Jamada
- Khisasi Takasugi
|
RU2164230C2 |
METHOD OF SYNTHESIS OF PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1990 |
- Matsuo Masaaki[Jp]
- Tsudzi Kiesi[Jp]
- Konisi Nobukie[Jp]
- Nakamura Katsuja[Jp]
|
RU2021990C1 |
PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1993 |
- Masaaki Matsuo
- Kijosi Tsudzi
- Takasi Ogino
- Nobukijo Konisi
|
RU2128172C1 |
GUANIDINE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND METHOD FOR INHIBITING Na/H EXCHANGE IN CELLS |
1994 |
- Atsusi Kuno
- Josikazu Inou
- Khisasi Takasugi
- Khiroaki Mizuno
- Kumi Jamasaki
|
RU2141946C1 |
AMIDINONAPHTYL DERIVATIVES AND PHARMACEUTICAL COMPOSITION |
1995 |
- Khirajama Fukusi
- Kosio Khirojuki
- Matsumoto Juzo
- Kavasaki Tomikhisa
- Kaku Sejdzi
- Janagisava Isao
|
RU2154633C2 |
ETHANOLAMINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT |
1993 |
- Juiti Siokava
- Masanobu Nagano
- Kijosi Taniguti
- Kazukhiko Take
- Takesi Kato
- Kazunori Tsubaki
|
RU2125983C1 |
AMINOPHOSPHATE DERIVATIVE AND S1P RECEPTOR MODULATOR CONTAINING SAID DERIVATIVE AS ACTIVE INGREDIENT |
2007 |
- Kokhno Jasushi
- Fudzhii Kijoshi
- Saito Tatsukhiro
|
RU2430925C2 |